Yu-Chen (Andy) Hu

Tuesday 2nd July 2024, 14:45-15:45
Intelligent CRISPR Design for Tissue Regeneration

Dr. Yu-Chen Hu is currently vice president of Asian Federation of Biotechnology. He is the deputy editor of Journal of Taiwan Institute of Chemical Engineers, Frontiers in Biotechnology and Bioengineering and editor of Scientific Report.  Dr. Hu is a pioneer using baculovirus for gene delivery, regenerative medicine and cancer therapy, making baculovirus a promising vector for gene therapy. Dr. Hu is a leader in CRISPR technology for tissue regeneration and metabolic engineering. He has combined RNA-guided CRISPR technology and synthetic biology to metabolically engineer microorganisms to produce a bio-derived chemical with the highest tiler in the world. Dr. Hu also develops various CRISPR and RNA editing platforms to modulate stem cell differentiation to improve regeneration of different tissues. Dr. Hu has been invited to deliver 95 speeches in international conferences, including 11 plenary speeches and 34 keynote speeches. Dr. Hu has won numerous academic awards and is a fellow of 5 academic societies. 


Visit us on Social Media

Please note: All information requested on the website and registration process is strictly for the use of the Congress in compliance with international privacy legislation. By completing this registration form you will agree that the Congress will use this data to keep you fully informed of the Congress in 2024. The data will then be retained by the Congress secretariat for the purposes of informing you about activities and future meetings. On the registration form, You will also have the opportunity to agree separately to allow key data (Name, Company, Email Address) to be shared with sponsors and exhibitors who are participating in the Congress in 2024. We will not pass any details to any companies not participating in the Congress in 2024.